Terms: = Lung cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Prognosis
7 results:
1. Head and Neck Malignant Paragangliomas: Experience from a Single Institution.
Ding Y; Li L; Han D; Wang S; Chen X
Ear Nose Throat J; 2024 May; 103(5):298-304. PubMed ID: 34654328
[No Abstract] [Full Text] [Related]
2. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.
Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV
Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576
[TBL] [Abstract] [Full Text] [Related]
3. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.
Cui H; Seubert B; Stahl E; Dietz H; Reuning U; Moreno-Leon L; Ilie M; Hofman P; Nagase H; Mari B; Krüger A
Oncogene; 2015 Jul; 34(28):3640-50. PubMed ID: 25263437
[TBL] [Abstract] [Full Text] [Related]
5. Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery.
Rafat C; Zinzindohoue F; Hernigou A; Hignette C; Favier J; Tenenbaum F; Gimenez-Roqueplo AP; Plouin PF; Amar L
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2681-5. PubMed ID: 25188716
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis.
Zhu W; Xu B
PLoS One; 2014; 9(8):e103373. PubMed ID: 25098165
[TBL] [Abstract] [Full Text] [Related]
7. A novel p53 mutant retained functional activity in lung carcinomas.
Ko JL; Chiao MC; Chang SL; Lin P; Lin JC; Sheu GT; Lee H
DNA Repair (Amst); 2002 Sep; 1(9):755-62. PubMed ID: 12509279
[TBL] [Abstract] [Full Text] [Related]
